Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Short term Debt: 2023-2025

  • Zhengye Biotechnology Holding's Short term Debt was N/A to $11.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $11.2 million, marking a year-over-year change of. This contributed to the annual value of $10.2 million for FY2024, which is 9.75% down from last year.
  • Zhengye Biotechnology Holding's Short term Debt amounted to $11.2 million in Q2 2025, which was up 9.61% from $10.2 million recorded in Q4 2024.
  • Zhengye Biotechnology Holding's Short term Debt's 5-year high stood at $11.2 million during Q2 2025, with a 5-year trough of $10.2 million in Q4 2024.
  • For the 3-year period, Zhengye Biotechnology Holding's Short term Debt averaged around $10.8 million, with its median value being $11.1 million (2023).
  • Data for Zhengye Biotechnology Holding's Short term Debt shows a maximum YoY fell of 8.05% (in 2024) over the last 5 years.
  • Over the past 3 years, Zhengye Biotechnology Holding's Short term Debt (Quarterly) stood at $11.1 million in 2023, then dropped by 8.05% to $10.2 million in 2024, then reached $11.2 million in 2025.
  • Its Short term Debt stands at $11.2 million for Q2 2025, versus $10.2 million for Q4 2024 and $11.1 million for Q4 2023.